Filters

Country

Capitalization

Sector

Categories

Add a keyword

Announcement Date

Since

Until

Popular Stocks

Wave Life Sciences Ltd.
WAVE LIFE SCIENCES LTD. +147.26%
Wave Life Sciences announces positive interim data from phase 1 inlight trial of WVE-007 for obesity
Structure Therapeutics Inc.
STRUCTURE THERAPEUTICS INC. +102.49%
Structure's experimental pill shows 11% weight loss in study, shares up
Kymera Therapeutics, Inc.
KYMERA THERAPEUTICS, INC. +41.55%
Kymera Therapeutics says KT-621 well-tolerated with no serious adverse events reported
Confluent, Inc.
CONFLUENT, INC. +29.08%
IBM Reportedly in Advanced Talks to Acquire Confluent for About $11 Billion
Terns Pharmaceuticals, Inc.
TERNS PHARMACEUTICALS, INC. +37.02%
Terns Pharmaceuticals says safety profile maintained with longer treatment duration
Ocular Therapeutix, Inc.
OCULAR THERAPEUTIX, INC. +28.06%
Ocular Therapeutix says SOL-1 topline data expected in first quarter 2026
Air Products & Chemicals, Inc.
AIR PRODUCTS & CHEMICALS, INC. -9.45%
Air Products and Yara in Advanced Negotiations to Partner on Low-Emission Ammonia Projects
Carvana Co.
CARVANA CO. +12.06%
Carvana set to join S&P 500, shares jump
Nurix Therapeutics, Inc.
NURIX THERAPEUTICS, INC. +18.68%
Nurix Therapeutics presents new data from the phase 1 trial of bexobrutideg in Waldenström macroglobulinemia at the 67th American Society of Hematology annual meeting and exposition
Warby Parker Inc.
WARBY PARKER INC. +13.27%
Warby Parker, Google to launch AI glasses in 2026
Cullinan Therapeutics, Inc.
CULLINAN THERAPEUTICS, INC. +17.47%
Cullinan Therapeutics says phase 1 CLN-049 monotherapy demonstrates promising efficacy
ITT Inc.
ITT INC. -6.35%
ITT announces public offering of 7,000,000 shares
HUYA Inc.
HUYA INC. +7.07%
Huya announces January 7, 2026 open beta launch for Goose Goose Duck mobile in Chinese mainland
Paramount Skydance Corporation
PARAMOUNT SKYDANCE CORPORATION +9.02%
Paramount Skydance: Ellison family, RedBird collectively committed to backstop 100% of $40.7 bln of equity capital required for deal - filing
Incyte Corporation
INCYTE CORPORATION -5.68%
Incyte gains FDA Breakthrough designation for its candidate against essential thrombocythemia
STAAR Surgical Company
STAAR SURGICAL COMPANY -7.25%
Staar Surgical announces expiration of go-shop period
Dyne Therapeutics, Inc.
DYNE THERAPEUTICS, INC. +9.47%
Dyne Therapeutics announces positive topline results from phase 1/2 Deliver trial
Plus d''actualités qui impactent
Dec. 08
DJ
Dec. 08
RE
Dec. 08
CI
Dec. 08
RE
Dec. 08
RE
Dec. 08
RE
Dec. 08
RE
Dec. 08
RE
Dec. 08
RE
Dec. 08
DJ
Dec. 08
DJ
Dec. 08
RE
Dec. 08
AN
Dec. 08
DJ
Dec. 08
RE
Dec. 08
RE
Dec. 08
RE
Dec. 08
RE
Dec. 08
DP
Dec. 08
RE
Dec. 08
RE
Dec. 08
RE
Dec. 07
DJ
Dec. 07
RE
Dec. 07
RE
Dec. 07
CI
Dec. 07
CI
Dec. 07
RE
Dec. 07
RE
Dec. 07
RE
Dec. 07
RE
Dec. 07
RE
Dec. 07
CI
Dec. 06
CI
Dec. 06
CI
Dec. 06
RE
Dec. 06
RE
Dec. 05
CI
Dec. 05
CI
Dec. 05
RE
Dec. 05
AN
Dec. 05
RE
Dec. 05
RE
Dec. 05
RE
Dec. 05
RE
Dec. 05
CI
Dec. 05
RE
Dec. 05
RE
Dec. 05
AN
Dec. 05
RE
No results for this search